NO20043001L - Farmasoytisk formulering omfattende cyklosporin og anvendelse derav - Google Patents

Farmasoytisk formulering omfattende cyklosporin og anvendelse derav

Info

Publication number
NO20043001L
NO20043001L NO20043001A NO20043001A NO20043001L NO 20043001 L NO20043001 L NO 20043001L NO 20043001 A NO20043001 A NO 20043001A NO 20043001 A NO20043001 A NO 20043001A NO 20043001 L NO20043001 L NO 20043001L
Authority
NO
Norway
Prior art keywords
weight
amount
cyclosporine
mucous membranes
pharmaceutical formulation
Prior art date
Application number
NO20043001A
Other languages
English (en)
Other versions
NO20043001D0 (no
NO327513B1 (no
Inventor
Johannes Wohlrab
Reinhard Neubert
Konstanze Jahn
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Publication of NO20043001D0 publication Critical patent/NO20043001D0/no
Publication of NO20043001L publication Critical patent/NO20043001L/no
Publication of NO327513B1 publication Critical patent/NO327513B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

Oppfinnelsen vedrører et farmasøytisk preparat i kolloidal form for topisk anvendelse, for terapi og profylakse av patologiske forandringer i huden og/eller kutane appendikser og/eller slimhinner, inkluderende slimhinner i fordøyelsessystemet, urogenitalsystemet, bronikalsystemet og/eller konjunktiva. Det nevnte preparat omfatter en lipofil fase i en mengde på 1-10 vekt%, en blanding av surfaktant og kosurfaktant i en mengde på 1-50 vekt%, en hydrofil fase i en mengde på 40-80 vekt% og cyklosporin eller derivater derav som aktiv bestanddel i en konsentrasjon på 0,1-20 vekt%.
NO20043001A 2001-12-14 2004-07-13 Farmasoytisk formulering omfattende cyklosporin og anvendelse derav NO327513B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2001/014749 WO2003051385A1 (de) 2001-12-14 2001-12-14 Arzneiformulierung enthaltend ciclosporin und deren verwendung

Publications (3)

Publication Number Publication Date
NO20043001D0 NO20043001D0 (no) 2004-07-13
NO20043001L true NO20043001L (no) 2004-09-14
NO327513B1 NO327513B1 (no) 2009-07-27

Family

ID=8164725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043001A NO327513B1 (no) 2001-12-14 2004-07-13 Farmasoytisk formulering omfattende cyklosporin og anvendelse derav

Country Status (18)

Country Link
US (1) US8568748B2 (no)
EP (1) EP1455810B1 (no)
JP (1) JP4251988B2 (no)
CN (1) CN100360175C (no)
AT (1) ATE364391T1 (no)
AU (1) AU2002231703B2 (no)
BR (1) BR0117197A (no)
CA (1) CA2470230C (no)
CZ (1) CZ302649B6 (no)
HU (1) HUP0402318A3 (no)
IL (1) IL162496A0 (no)
IS (1) IS7311A (no)
MX (1) MXPA04005783A (no)
NO (1) NO327513B1 (no)
NZ (1) NZ534061A (no)
RO (1) RO123110B1 (no)
UA (1) UA79766C2 (no)
WO (1) WO2003051385A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
DE10330243A1 (de) 2003-07-03 2005-01-20 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
CA2597590A1 (en) 2005-02-09 2006-08-17 Macusight, Inc. Formulations for ocular treatment
WO2007011880A2 (en) 2005-07-18 2007-01-25 Minu, L.L.C. Enhanced ocular neuroprotection/neurostimulation
BRPI0707612B8 (pt) 2006-02-09 2021-05-25 Macusight Inc vaso lacrado e formulações líquidas contidas no mesmo
BRPI0709016A2 (pt) 2006-03-23 2011-06-21 Macusight Inc formulações e métodos para doenças ou condições relacionadas com a permeabilidade vascular
US9561178B2 (en) * 2006-07-25 2017-02-07 Allergan, Inc. Cyclosporin compositions
WO2009034604A1 (ja) 2007-09-10 2009-03-19 Maruho Co., Ltd. シクロスポリンを含有する液晶乳化型医薬組成物およびそれを用いた皮膚疾患の治療方法
DE102008015299A1 (de) * 2008-03-18 2009-09-24 Pkh Gmbh Halle Kolloidales Trägersystem
EP2308468A1 (en) * 2009-10-08 2011-04-13 Novaliq GmbH Novel pharmaceutical composition comprising a macrolide immunosuppressant drug
DE102013211039A1 (de) * 2013-06-13 2014-12-18 Skinomics GmbH Galenische Formulierung in kolloidaler Form enthaltend Ceramid-Oligomere und deren Verwendung
US20150147382A1 (en) * 2013-09-23 2015-05-28 Exir Nano Sina Company Topical liposomal compositions for delivering hydrophobic drugs and methods preparing same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH679119A5 (no) 1988-05-13 1991-12-31 Sandoz Ag
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
NZ243703A (en) 1991-07-26 1995-12-21 Smithkline Beecham Corp Pharmaceutically acceptable, stable, self-emulsifying w/o microemulsions containing a water-soluble therapeutic agent, microemulsions
WO1994008603A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Compositions
WO1994008605A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Corporation Therapeutic microemulsions
DE4322826A1 (de) 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
KR0167613B1 (ko) * 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
EP0760237A1 (en) 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
NZ280689A (en) 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
US5660858A (en) * 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
IT1298575B1 (it) 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
DE10029404B4 (de) * 2000-06-15 2009-10-29 Jagotec Ag Arzneiformulierung enthaltend Ciclosporin und deren Verwendung
US6809077B2 (en) * 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases

Also Published As

Publication number Publication date
NZ534061A (en) 2006-01-27
ATE364391T1 (de) 2007-07-15
WO2003051385A1 (de) 2003-06-26
BR0117197A (pt) 2004-12-14
CA2470230C (en) 2012-01-24
CN100360175C (zh) 2008-01-09
IL162496A0 (en) 2005-11-20
NO20043001D0 (no) 2004-07-13
MXPA04005783A (es) 2004-09-13
CZ302649B6 (cs) 2011-08-17
JP4251988B2 (ja) 2009-04-08
US8568748B2 (en) 2013-10-29
CZ2004778A3 (cs) 2004-11-10
HUP0402318A2 (hu) 2005-02-28
AU2002231703B2 (en) 2007-03-29
RO123110B1 (ro) 2010-11-30
HUP0402318A3 (en) 2012-09-28
US20050106189A1 (en) 2005-05-19
AU2002231703A1 (en) 2003-06-30
NO327513B1 (no) 2009-07-27
UA79766C2 (en) 2007-07-25
EP1455810B1 (de) 2007-06-13
JP2005516931A (ja) 2005-06-09
CN1582161A (zh) 2005-02-16
CA2470230A1 (en) 2003-06-26
IS7311A (is) 2004-06-14
EP1455810A1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
NO20043001L (no) Farmasoytisk formulering omfattende cyklosporin og anvendelse derav
CA2292796A1 (fr) Nanoemulsion a base d'esters gras de sorbitan oxyethylenes ou non oxyethylenes, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
ITBO20050388A1 (it) Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
ES2188115T3 (es) Nanoemulsion a base de esteres grasos de azucar o de eteres grasos de azucar y sus utilizaciones en los ambitos cosmetico, dermatologico y/u oftalmologico.
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
ATE526956T1 (de) Viruzide zusammensetzungen
KR20060004667A (ko) 피부과 질병 치료용 이버멕틴의 외용 제형물
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
WO2005087195A3 (en) Novel compositions for topical delivery
US6306383B1 (en) Method for topical treatment of scars with protein kinase C inhibitors
US6881756B2 (en) Method for treating skin disorders
JP2004507496A5 (no)
US20070128287A1 (en) Dermal composition for external use
AR046226A1 (es) Formulaciones farmaceuticas que contienen saborizante con caracteristicas farmaceuticas mejoradas
JP2002212107A (ja) 局所適用組成物
JPH07277988A (ja) 局所用掻痒除去、治療剤
JPH0255404B2 (no)
ITMI20012142A1 (it) Composizioni farmaceutiche per uso topico contenenti estratti di erbemedicinali ad attivita' antilogistica e cicatrizzante
CA2429793A1 (en) Interferon therapeutic effect enhancer
JP2007262031A (ja) 知覚過敏型肌掻痒感改善剤
JP2005060386A (ja) 皮膚外用剤
WO2023120583A1 (ja) にきび用外用組成物及びアクネ菌選択的抗菌・殺菌用外用組成物
JP2000229852A (ja) 皮膚外用剤
AU2011244985B2 (en) Gum resin as a carrier for topical application of pharmacologically active agents
CN117083057A (zh) 用于预防感染的组合物

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees